Senseonics Holdings (SENS) Tops Q4 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results
March 12, 2019 4:05 PM EDTGERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the fourth quarter and full year ended December31,2018.
RECENT HIGHLIGHTS & ACCOMPLISHMENTS:
Received positive reimbursement decisions for Eversense® from several payors with coverage reaching approximately 60 million lives in the U.S. Obtained Regulatory approval to expand Eversense certification to Nurse Practitioners and Physician... More